The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Stem Cell Exosome Therapeutic Market Research Report 2024

Global Stem Cell Exosome Therapeutic Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1738352

No of Pages : 96

Ask Your Query

Synopsis
Exosome therapy involves using exosomes, small vesicles that are naturally produced by stem cells, to deliver therapeutic molecules to specific cells in the body.

Global Stem Cell Exosome Therapeutic market is projected to reach US$ 410.5 million in 2029, increasing from US$ 153 million in 2022, with the CAGR of 15.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Stem Cell Exosome Therapeutic market research.

Key companies engaged in the Stem Cell Exosome Therapeutic industry include Aegle Therapeutics, Brexogen, Cell Care Therapeutics, CHA Biotech, ExoCoBio, Exopharm, OmniSpiant, BrainStorm Cell Therapeutics and Novadip Biosciences, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Stem Cell Exosome Therapeutic were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Stem Cell Exosome Therapeutic market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Stem Cell Exosome Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Aegle Therapeutics
  • Brexogen
  • Cell Care Therapeutics
  • CHA Biotech
  • ExoCoBio
  • Exopharm
  • OmniSpiant
  • BrainStorm Cell Therapeutics
  • Novadip Biosciences
  • Unicyte AG
  • Exogenus Therapeutics
  • Creative Medical Tech
  • Anjarium Biosciences
  • Capricor Therapeutics
  • Kimera Labs ReNeuron
  • Stem Cell Medicine
  • Codiak Biosciencesare

Segment by Type

  • Mesenchymal Stem Cell (MSC)
  • Dendritic Cells
  • Umbilical MSC
  • Others

Segment by Application

  • Precision Medicine
  • Regenerative Medicine
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Stem Cell Exosome Therapeutic report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Exosome Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Mesenchymal Stem Cell (MSC)
1.2.3 Dendritic Cells
1.2.4 Umbilical MSC
1.2.5 Others
1.3 Market by Application
1.3.1 Global Stem Cell Exosome Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Precision Medicine
1.3.3 Regenerative Medicine
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Exosome Therapeutic Market Perspective (2018-2029)
2.2 Stem Cell Exosome Therapeutic Growth Trends by Region
2.2.1 Global Stem Cell Exosome Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Stem Cell Exosome Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Stem Cell Exosome Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Stem Cell Exosome Therapeutic Market Dynamics
2.3.1 Stem Cell Exosome Therapeutic Industry Trends
2.3.2 Stem Cell Exosome Therapeutic Market Drivers
2.3.3 Stem Cell Exosome Therapeutic Market Challenges
2.3.4 Stem Cell Exosome Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Exosome Therapeutic Players by Revenue
3.1.1 Global Top Stem Cell Exosome Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Stem Cell Exosome Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Stem Cell Exosome Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Stem Cell Exosome Therapeutic Revenue
3.4 Global Stem Cell Exosome Therapeutic Market Concentration Ratio
3.4.1 Global Stem Cell Exosome Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Exosome Therapeutic Revenue in 2022
3.5 Stem Cell Exosome Therapeutic Key Players Head office and Area Served
3.6 Key Players Stem Cell Exosome Therapeutic Product Solution and Service
3.7 Date of Enter into Stem Cell Exosome Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Exosome Therapeutic Breakdown Data by Type
4.1 Global Stem Cell Exosome Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Stem Cell Exosome Therapeutic Forecasted Market Size by Type (2024-2029)
5 Stem Cell Exosome Therapeutic Breakdown Data by Application
5.1 Global Stem Cell Exosome Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Stem Cell Exosome Therapeutic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Stem Cell Exosome Therapeutic Market Size (2018-2029)
6.2 North America Stem Cell Exosome Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Stem Cell Exosome Therapeutic Market Size by Country (2018-2023)
6.4 North America Stem Cell Exosome Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Exosome Therapeutic Market Size (2018-2029)
7.2 Europe Stem Cell Exosome Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Stem Cell Exosome Therapeutic Market Size by Country (2018-2023)
7.4 Europe Stem Cell Exosome Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Exosome Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Stem Cell Exosome Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Stem Cell Exosome Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Stem Cell Exosome Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cell Exosome Therapeutic Market Size (2018-2029)
9.2 Latin America Stem Cell Exosome Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Stem Cell Exosome Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Stem Cell Exosome Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Exosome Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Stem Cell Exosome Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Stem Cell Exosome Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Stem Cell Exosome Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aegle Therapeutics
11.1.1 Aegle Therapeutics Company Detail
11.1.2 Aegle Therapeutics Business Overview
11.1.3 Aegle Therapeutics Stem Cell Exosome Therapeutic Introduction
11.1.4 Aegle Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.1.5 Aegle Therapeutics Recent Development
11.2 Brexogen
11.2.1 Brexogen Company Detail
11.2.2 Brexogen Business Overview
11.2.3 Brexogen Stem Cell Exosome Therapeutic Introduction
11.2.4 Brexogen Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.2.5 Brexogen Recent Development
11.3 Cell Care Therapeutics
11.3.1 Cell Care Therapeutics Company Detail
11.3.2 Cell Care Therapeutics Business Overview
11.3.3 Cell Care Therapeutics Stem Cell Exosome Therapeutic Introduction
11.3.4 Cell Care Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.3.5 Cell Care Therapeutics Recent Development
11.4 CHA Biotech
11.4.1 CHA Biotech Company Detail
11.4.2 CHA Biotech Business Overview
11.4.3 CHA Biotech Stem Cell Exosome Therapeutic Introduction
11.4.4 CHA Biotech Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.4.5 CHA Biotech Recent Development
11.5 ExoCoBio
11.5.1 ExoCoBio Company Detail
11.5.2 ExoCoBio Business Overview
11.5.3 ExoCoBio Stem Cell Exosome Therapeutic Introduction
11.5.4 ExoCoBio Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.5.5 ExoCoBio Recent Development
11.6 Exopharm
11.6.1 Exopharm Company Detail
11.6.2 Exopharm Business Overview
11.6.3 Exopharm Stem Cell Exosome Therapeutic Introduction
11.6.4 Exopharm Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.6.5 Exopharm Recent Development
11.7 OmniSpiant
11.7.1 OmniSpiant Company Detail
11.7.2 OmniSpiant Business Overview
11.7.3 OmniSpiant Stem Cell Exosome Therapeutic Introduction
11.7.4 OmniSpiant Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.7.5 OmniSpiant Recent Development
11.8 BrainStorm Cell Therapeutics
11.8.1 BrainStorm Cell Therapeutics Company Detail
11.8.2 BrainStorm Cell Therapeutics Business Overview
11.8.3 BrainStorm Cell Therapeutics Stem Cell Exosome Therapeutic Introduction
11.8.4 BrainStorm Cell Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.8.5 BrainStorm Cell Therapeutics Recent Development
11.9 Novadip Biosciences
11.9.1 Novadip Biosciences Company Detail
11.9.2 Novadip Biosciences Business Overview
11.9.3 Novadip Biosciences Stem Cell Exosome Therapeutic Introduction
11.9.4 Novadip Biosciences Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.9.5 Novadip Biosciences Recent Development
11.10 Unicyte AG
11.10.1 Unicyte AG Company Detail
11.10.2 Unicyte AG Business Overview
11.10.3 Unicyte AG Stem Cell Exosome Therapeutic Introduction
11.10.4 Unicyte AG Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.10.5 Unicyte AG Recent Development
11.11 Exogenus Therapeutics
11.11.1 Exogenus Therapeutics Company Detail
11.11.2 Exogenus Therapeutics Business Overview
11.11.3 Exogenus Therapeutics Stem Cell Exosome Therapeutic Introduction
11.11.4 Exogenus Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.11.5 Exogenus Therapeutics Recent Development
11.12 Creative Medical Tech
11.12.1 Creative Medical Tech Company Detail
11.12.2 Creative Medical Tech Business Overview
11.12.3 Creative Medical Tech Stem Cell Exosome Therapeutic Introduction
11.12.4 Creative Medical Tech Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.12.5 Creative Medical Tech Recent Development
11.13 Anjarium Biosciences
11.13.1 Anjarium Biosciences Company Detail
11.13.2 Anjarium Biosciences Business Overview
11.13.3 Anjarium Biosciences Stem Cell Exosome Therapeutic Introduction
11.13.4 Anjarium Biosciences Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.13.5 Anjarium Biosciences Recent Development
11.14 Capricor Therapeutics
11.14.1 Capricor Therapeutics Company Detail
11.14.2 Capricor Therapeutics Business Overview
11.14.3 Capricor Therapeutics Stem Cell Exosome Therapeutic Introduction
11.14.4 Capricor Therapeutics Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.14.5 Capricor Therapeutics Recent Development
11.15 Kimera Labs ReNeuron
11.15.1 Kimera Labs ReNeuron Company Detail
11.15.2 Kimera Labs ReNeuron Business Overview
11.15.3 Kimera Labs ReNeuron Stem Cell Exosome Therapeutic Introduction
11.15.4 Kimera Labs ReNeuron Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.15.5 Kimera Labs ReNeuron Recent Development
11.16 Stem Cell Medicine
11.16.1 Stem Cell Medicine Company Detail
11.16.2 Stem Cell Medicine Business Overview
11.16.3 Stem Cell Medicine Stem Cell Exosome Therapeutic Introduction
11.16.4 Stem Cell Medicine Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.16.5 Stem Cell Medicine Recent Development
11.17 Codiak Biosciencesare
11.17.1 Codiak Biosciencesare Company Detail
11.17.2 Codiak Biosciencesare Business Overview
11.17.3 Codiak Biosciencesare Stem Cell Exosome Therapeutic Introduction
11.17.4 Codiak Biosciencesare Revenue in Stem Cell Exosome Therapeutic Business (2018-2023)
11.17.5 Codiak Biosciencesare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock